CalciMedica (CALC) Misses Q2 EPS by 19c

CalciMedica (NASDAQ: CALC) reported Q2 EPS of ($0.45), $0.19 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on CalciMedica (CALC) click here.

You May Also Be Interested In

• UGI shares spike on reported KKR bid for the company
• WaterBridge Infrastructure (WBI) PT Raised to $40 at Raymond James
• iQIYI (IQ) PT Lowered to $1.10 at Morgan Stanley